Abstract
To preliminarily investigate the possible role of prostaglandin D2 (PGD2) in malaria infections. Blood and urinary samples (n=120 each) were collected from Thai patients with Plasmodium falciparum (P.falciparum) with moderate (n=26) and high (n=4) parasitemia, patients with Plasmodium vivax (P.vivax) (n=30), patients with fever associated with other infections (n=30), and healthy subjects (n=30). PGD2 concentrations in plasma and urinary samples of healthy subjects, patients with fever associated with other infections and patients with malaria were determined using Prostaglandin D2-MOX express EIA kit (Cayman Chemical, USA). The possible association between PGD2 and malaria infections is clearly demonstrated with PGD2 concentration in urine. The urinary PGD2 concentrations were relatively high (about 5-fold) in patients with P.falciparum with moderate parasitemia and P.vivax infections compared with other groups. Furthermore, the concentration in patients with P.falciparum with moderate parasitemia and P.vivax infection were significantly higher than that in healthy subjects and patients with fever associated with other infections. Urinary PGD2 concentrations may offer a more dependable and useful tool for predicting malaria severity. Confirmation is this preliminary finding is required with a larger sample size.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.